Delivery Order SPE2D018D0006-SPE2D325F5656
Award Date
2/5/25
Potential Completion Date
2/10/25
Potential Value
$5.3K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a ceiling value of $5,292.66 and a period of performance through February 10, 2025. Eagle Pharmaceuticals is the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
This is a firm fixed-price delivery order contract (SPE2D018D0006|SPE2D325F4806) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Ryanodex (250 mg vials), a drug used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $10,585.32 and an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program. Eagle...
This federal contract award is a delivery order (SPE2D018D0006|SPE2D325F5039) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals"), a for-profit pharmaceutical manufacturer. The contract, valued at $5,292.66, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set-aside and is part of a larger...
This federal contract award, valued at $10,585.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250mg vials. Ryanodex is a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a delivery order with a firm fixed-price pricing type and a performance period ending on January 29, 2025. This award is not associated with a set-aside designation,...
This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,283.20, is for the delivery of Ryanodex 250 mg vials, a specialty medication, to support military and government medical programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of RYANODEX 250 MG VIALS, a medication, with a ceiling value of $1,489.64 and a completion date of September 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables...
The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 250 mg vials of the pharmaceutical product Ryanodex. The award is valued at $4,623.36 and has an ultimate completion date of January 13, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the...